Early Intervention can Lead to Prevention Of Postoperative Atrial Fibrillation after Cardiac Surgery

Posterior left pericardiotomy can help reduce new-onset atrial fibrillation is suggested by a late-breaking science presented by prominent researchers and cardiothoracic surgeon Dr. Gaudino at American Heart Association 2021 virtual conference on November 14, 2021. Atrial fibrillation(AF) is the most common complication after cardiac surgery, and the incidence ranges from 15-50%.1 The incidence of postoperative … Read more

Lessons from Legends in Cardiovascular Nursing

A significant portion of the AHA 2021 Scientific Sessions was focused on mentorship for early career individuals in research and medicine. Insights from the Interview with Nursing Legends in Cardiovascular Science were particularly illuminating. During this session, Dr. Christopher Lee, Professor and Associate Dean for Research at the Boston College William F. Connell School of … Read more

Channeling Health Care Delivery and Implementation Science in Cardiology for Improved Outcomes

The opening session for AHA21 was nothing sort of inspirational. In the opening session, a quote by Dr. Keith Ferdinand, Professor of Medicine and Chair of Preventative Cardiology at Tulane University, really stuck with me. The topic was how is the field of medicine adjusting in the midst of the challenges faced and inequities uncovered … Read more

Adding to Statins: Achieving Optimum Reduction of “Bad” Cholesterol

Atherosclerotic cardiovascular disease (ASCVD) is the number one cause of death in the Western world.[1] Since 2016, cardiovascular diseases have caused 1 in 3 deaths in the United States, and this trend is expected to continue in the future. There is a well-established relationship between ASCVD and elevated levels of low-density lipoprotein C (LDL-C), often … Read more

#AHA21: Matching Into Cardiology Fellowship: The Inside Scoop from Program Directors

We were lucky enough to hear from some exceptional PDs and APDs during #AHA21. The process of applying to cardiology fellowship can be daunting. These discussions provide amazing tips and insight on the process so we can best prepare. What catches your eye on CVs? Although this will vary by program and individual, a few … Read more

Cancer Warriors losing battle to heart disease?

Your cancer treatment may be over, but does it continue to cause side effects to your body? Chemotherapy and radiation have revolutionized the survival rates among cancer patients, but so is the development of cardiovascular diseases (CVD) in cancer survivors. The scientific session 2021 program committee organized an educational session on cardio-oncology, which included talks … Read more

Forever Young at Heart: Aging and Cardiovascular Risk

One of the hot topics from this year’s AHA21 Scientific Sessions main event was how to promote healthy vascular aging. Age is the strongest predictor for cardiovascular (CV) risk and risk factors such as genetic predisposition and hyperlipidemia increase CV risk. The general recommendations to reduce CV risk were elegantly presented by Dr Roger S. … Read more

Being an Early Career Investigator at AHA21

Over 50 emerging scientists and clinicians were among the finalists of the Early Career Investigator Award in AHA Scientific Sessions 2021. These prestigious awards were designed to recognize the marvelous endeavors by early career investigators who submitted their abstracts to AHA Scientific Sessions 2021. The selection process included not only the quality of the abstracts … Read more

BREAKING: Trials From the Realm of Cardiac Electrophysiology to Look Forward to in AHA Scientific Sessions 2021

The most anticipated cardiovascular conference of the year, AHA Scientific Sessions 2021 is upon us! In the days and hours leading upto the event, speakers have been revising their presentations, moderators going over their notes, and organizers working hard to prevent any glitches for this fully virtual experience. For many attendees, including myself, the most … Read more